Description
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog (engineered to mimic a natural fragment) that stimulates the pituitary gland to release endogenous growth hormone in a pulsatile manner. Clinically, FDA-approved use in reducing excess visceral (abdominal) fat in patients with HIV-associated lipodystrophy.
Visceral Fat Reduction: It has a strong clinical track record for targeting metabolically dangerous deep belly fat surrounding the internal organs, generally spares subcutaneous fat while preserving lean muscle mass.
Tesamorelin is supplied as 10mg lyophilized powder, ≥99% purity. For laboratory research use only. Not for human consumption or therapeutic use. Certificate of Analysis available on request. Store at -20°C.
CAS Number: 218949-48-5
SEQUENCE: YADAIFTNSY RKVLGQLSAR KLLQDIMSRQ QGESNQERGA RARL-NH₂
Amino Acid Chain Length: 44 residues with an N-terminal trans-3-hexenoic acid modification
Molecular Formula: C221H366N72O67S
• FDA approved
• 99% Pure
• Independent Lab Tested

Reviews
There are no reviews yet.